WHO it has granted its first authorization for use of a vaccine against mpox in adults, calling it an step toward fighting the disease in Africa.
WHO grants first mpox vaccine approval to ramp up response to disease in Africa
The World Health Organization said Friday it has granted its first authorization for use of a vaccine against mpox in adults, calling it an important step toward fighting the disease in Africa.
The approval of the vaccine by Bavarian Nordic A/S means that donors like vaccines alliance Gavi and UNICEF can buy it. But supplies are limited because there’s only a single manufacturer.
« This first (authorization) of a vaccine against mpox is an important step in our fight against the disease, both in the context of the current outbreaks in Africa, and in future », said WHO Director-General Tedros Adhanom Ghebreyesus.
The U.N. health agency chief called for « urgent » scale-up of procurement, donations and rollout to get the vaccine where it is needed most, along with other response measures.
